Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation

Ann Diagn Pathol. 2006 Oct;10(5):263-8. doi: 10.1016/j.anndiagpath.2005.12.011.

Abstract

Plasma cell leukemia (PCL) is a neoplastic disorder of plasma cells of which there are 2 forms, primary PCL and secondary PCL, the latter occurring in patients with a history of plasma cell myeloma. We describe 4 patients with primary PCL. In all cases, the bone marrow aspirate smears and biopsy specimens demonstrated a diffuse infiltrate of atypical plasma cells that were difficult to classify using morphologic criteria alone. Immunophenotypic studies showed that each case was positive for plasma cell-associated antigens (cytoplasmic immunoglobin, CD38, or CD138) and negative for CD20. Of 4 cases, 3 had complex karyotypes, including the t(11;14)(q13;q32) or del(11)(q13). Despite chemotherapy and the use of novel therapeutic agents and stem cell transplantation, all 4 patients had short survival.

Publication types

  • Case Reports

MeSH terms

  • ADP-ribosyl Cyclase 1 / metabolism
  • Adult
  • Bone Marrow / pathology
  • Combined Modality Therapy
  • Female
  • Humans
  • Immunophenotyping
  • Karyotyping
  • Leukemia, Plasma Cell / diagnosis
  • Leukemia, Plasma Cell / drug therapy*
  • Leukemia, Plasma Cell / immunology
  • Leukemia, Plasma Cell / pathology*
  • Male
  • Membrane Glycoproteins / metabolism
  • Middle Aged
  • Plasma Cells / immunology
  • Plasma Cells / pathology
  • Proteoglycans / metabolism
  • Stem Cell Transplantation*
  • Survival Analysis
  • Syndecan-1
  • Syndecans

Substances

  • Membrane Glycoproteins
  • Proteoglycans
  • SDC1 protein, human
  • Syndecan-1
  • Syndecans
  • ADP-ribosyl Cyclase 1